指南与共识传染病防控与疫情报告卫生政策与健康促进

全国结核菌素皮肤试验抗原短缺:CDC患者护理与公共卫生实践建议

Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice.
指南 / 共识 · MMWR Morb Mortal Wkly Rep · 2019-06-21

CDC预计Aplisol(一种FDA许可的PPD结核菌素抗原)将出现3-10个月的全国性短缺,该时间框架为生产商当前估计且可能变化。本报告包含CDC为缓解Aplisol短缺导致的结核病检测能力下降而提出的建议。

要点

  • CDC建议见报告,用于缓解结核病检测能力下降。

核心结论

  • CDC预计Aplisol将出现3-10个月全国性短缺,并发布建议以缓解结核病检测能力下降。

研究设计与样本

  • CDC基于生产商通知发布的指南,涉及FDA许可的两种PPD结核菌素抗原之一的Aplisol供应中断。

主要发现

  • 短缺时间框架为生产商当前估计,可能变化,供应状态将在FDA网站更新。

关键数值与推荐

  • Aplisol短缺预计持续3-10个月。
  • 5 mL规格(50多剂量瓶)供应中断始于2019年6月。

临床怎么用

  • CDC建议见本报告,用于缓解Aplisol短缺导致的结核病检测能力下降。

局限性

  • 短缺时间框架为生产商当前估计且可能变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CDC is expecting a 3-10 month nationwide shortage of Aplisol, a product of Par Pharmaceuticals, and one of two purified-protein derivative (PPD) tuberculin antigens licensed by the Food and Drug Administration (FDA) for use in performing tuberculin skin tests. This time frame is the manufacturer's current estimate and is subject to change. The manufacturer notified CDC that they anticipate an interruption of supply of Aplisol 5 mL (50 multidose vials) beginning in June 2019, followed by an interruption of the supply of Aplisol 1 mL (10 multidose vials) in November 2019. The expected shortage of Aplisol 1 mL could occur before November 2019 if demand increases before then. Information on the status of this supply interruption will be updated at FDA's Center for Biologics Evaluation and Research-Regulated Products: Current Shortages website (https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/cber-regulated-products-current-shortages). This report includes CDC recommendations for mitigating a reduction in tuberculosis (TB) testing capability resulting from the anticipated Aplisol shortage (1).

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31220054. doi:10.15585/mmwr.mm6824a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。